By Sammy CRABBEInfrastructure alone does not make a city great. Roads, grids, and buildings create the skeleton, but it is innovation, creativity, and collaboration that breathe life into the body. As ...

Research suggests women with high breast cancer risk and menopausal symptoms could benefit from Duavee, which reduced breast ...

New research presented at the 2025 American Society for Clinical Oncology’s (ASCO) annual meeting has shed light on the ...

BDC-4182 Phase 1 dose-escalation study now open for enrollmentBDC-3042 Phase 1 dose-escalation data presented at AACR 2025 demonstrated a favorable safety profile, dose-dependent biological activity ...

Under the new law, anyone in Montana can legally access drugs that have passed just one phase 1 clinical trial.

The African Medical Centre of Excellence (AMCE) officially opened today, marking a historic milestone in Africa's journey ...

The trial is evaluating EB103, which is a CD19-redirected ARTEMIS® T-cell therapy, in adult patients (aged 18 and older) with ...

The analysts are supporting the company’s potential in the broader mental health sector, demonstrating the transformative ...

The Food and Drug Administration has approved Zoryve (roflumilast) topical foam, 0.3% for plaque psoriasis of the scalp and body.

MRD positivity or reappearance was prognostic for earlier clinical relapse. This study leverages a large phase III trial to demonstrate the association of MRD status with outcomes in patients with FL.

An analysis of pooled data from two large finerenone trials identified key risk factors for hyperkalemia in patients with CKD ...

The drug, Mazdutide, is the world's first and currently only GCG/GLP-1 dual receptor agonist targeting both weight loss and ...